ADJUVANT PARTNERS
Adjuvant Partners is the only life sciences business development and strategic consulting practice.
ADJUVANT PARTNERS
Industry:
Biotechnology Consulting Health Care Life Science
Address:
Towson, Maryland, United States
Country:
United States
Website Url:
http://www.adjuvant.com
Total Employee:
1+
Status:
Active
Contact:
202-345-3675
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta Euro Google Font API Content Delivery Network Pound Sterling Typekit LocalBusiness Schema Squarespace FLoC Opt-Out Cloudflare Turnstile
Similar Organizations
Africa Biosystems Limited
Africa Biosystems Limited provides life sciences equipment and consumables.
Amid Biosciences LLC
Amid Biosciences develops and manufactures products to simplify and improve life science research.
Marcus & Associates | Life Sciences Executive Search Experts
Marcus & Associates is a leading life sciences executive search firm helping clients acquire the industry's' most talented individuals.
Pukana Partners
Pukana Partners is a life sciences business consulting company
The Kinetix Group
The Kinetix Group helps life science companies with healthcare delivery strategies and tactical services.
Current Employees Featured
Official Site Inspections
http://www.adjuvant.com
- Host name: 172.67.213.165
- IP address: 172.67.213.165
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Adjuvant Partners"
Areas of Expertise — Adjuvant Partners
This can take the form of advocacy, education, and network development and is a key component of any private organization seeking government partners or funding. For life sciences government relations services, Adjuvant partners …See details»
Morrie Ruffin — Adjuvant Partners
He is the co-founder of the Alliance for Regenerative Medicine (ARM), the global organization representing the interests of the cell and gene therapy and tissue engineering communities. Mr. Ruffin built the organization and let it to its …See details»
Adjuvant Partners - Crunchbase Company Profile
Adjuvant Partners is the only life sciences business development and strategic consulting practice.See details»
Adjuvant Capital
Adjuvant is a life sciences investment fund that backs ambitious companies developing drugs, vaccines, diagnostics, medical devices, and other technologies to address critical global public health challenges.See details»
Adjuvant Partners - LinkedIn
At Adjuvant Partners, we leverage our expertise, professional network, and pan-industry perspectives to provide unique, tailored solutions to our clients to best suit their needs.See details»
Adjuvant Health - Crunchbase Company Profile
Adjuvant Health offers healthcare consulting, healthcare marketing, medical IT security, culture and leadership training, physician mentoring and coaching, and practice rescue.See details»
Adjuvant Capital - Crunchbase Investor Profile
Adjuvant Capital is a life sciences investment firm focused on global health. The company makes $10-$25 million investments in ambitious companies targeting opportunities in high burden and neglected disease.See details»
Adjuvant Capital | Devex
Learn more about Adjuvant Capital's jobs, projects, latest news, contact information and geographical presence. The Adjuvant model pursues meaningful, measurable social impact on …See details»
Team (archive) — Adjuvant Partners
Bethany joined Adjuvant Partners in early 2012, and brings nearly 20 years of finance, operations and marketing experience to the team. She has specific expertise in building and managing …See details»
Adjuvant Capital
Adjuvant Capital is a life sciences investment firm focused on global health. We make $10-$25 million investments in ambitious companies targeting opportunities in high burden and …See details»
Adjuvant Capital: Investment in Health Innovations
Apr 16, 2021 Glenn Rockman and Jenny Yip are the leaders of Adjuvant Capital, an investment firm focused on public health innovations to improve global health.See details»
Adjuvant rakes in $300m for debut public health fund
Feb 18, 2021 Adjuvant Capital has raised $300 million for its new venture fund focused on improving global public health.See details»
about - Adjuvant Capital
Adjuvant is a life sciences investment fund that backs ambitious companies developing drugs, vaccines, diagnostics, medical devices, and other technologies to address critical global public …See details»
Adjuvant Capital announces $300m venture fund to improve …
Adjuvant Capital announced an oversubscribed $300 million fund focused on accelerating the development of medical innovations for historically overlooked public health challenges.See details»
Oncology Adjuvants Market Size, Share & Growth [2025 To 2033]
Mar 17, 2025 ONCOLOGY ADJUVANTS MARKET REPORT OVERVIEW The global Oncology Adjuvants Market size was USD 0.52 billion in 2024 and is expected to reach USD 0.71 billion …See details»
Imfinzi-based regimen demonstrated statistically significant and ...
Mar 7, 2025 MATTERHORN MATTERHORN is a randomised, double-blind, placebo-controlled, multi-centre, global Phase III trial evaluating Imfinzi as perioperative treatment for patients with …See details»
Bethany Kraynack — Adjuvant Partners
Bethany joined Adjuvant Partners in early 2012, and brings nearly 20 years of finance, operations and marketing experience to the team. She has specific expertise in building and managing …See details»
Clariant announces simplified organizational and leadership …
Clariant today announced changes to its leadership and organizational structure as part of the company’s ongoing initiatives to implement its purpose-led strategy and cultural transformation.See details»
Adjuvant Therapy: Purpose, Benefits, Side Effects - Health
Sep 20, 2024 Adjuvant cancer treatments such as chemotherapy and radiation are given after a primary cancer treatment to help prevent cancer recurrence.See details»
Team — Adjuvant Partners
The collective expertise of our team members ensures our diverse clientele will reach their full potential.See details»